The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Change in Natural History of Duchenne Muscular Dystrophy With Long-term Corticosteroid Treatment: Implications for Management
Abstract
In 2005, the American Academy of Neurology and the Child Neurology Society published a practice parameter, based primarily on studies that involved 6 to 18 months of treatment, indicating that prednisone has a beneficial effect on muscle strength and function in patients with Duchenne muscular dystrophy and recommended that corticosteroids be offered (prednisone 0.75 mg/kg/d and deflazacort 0.9 mg/kg/d) as treatment. Recent reports emphasize that longer term treatment with corticosteroids (greater than 3 years) produces important sustained benefits in neuromuscular function without causing major side effects. This review highlights these reports and indicates that long-term corticosteroid therapy (1) prolongs ambulation by 2 to 5 years, (2) reduces the need for spinal stabilization surgery, (3) improves cardiopulmonary function, (4) delays the need for noninvasive nasal ventilation, and (5) increases survival and the quality of life of patients with Duchenne muscular dystrophy. Educational, vocational, and other social counseling is now a vital part of management for Duchenne muscular dystrophy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bushby, K., Finkel, R., Birnkrant, D. J., Case, L. E., Clemens, P. R., Cripe, L., Kaul, A., Kinnett, K., McDonald, C., Pandya, S., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70271-6 · Cited by 2,053
Self-citationBushby, K., Finkel, R., Birnkrant, D. J., Case, L. E., Clemens, P. R., Cripe, L., Kaul, A., Kinnett, K., McDonald, C., Pandya, S., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70272-8 · Cited by 1,172
Self-citationEagle, M., Baudouin, S. V., Chandler, C., Giddings, D. R., Bullock, R., & Bushby, K. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00140-2 · Cited by 1,009
Glucocorticoid corticosteroids for Duchenne muscular dystrophy
Manzur, A., Kuntzer, T., Pike, M., & Swan, A. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003725.pub2 · Cited by 539
Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular Dystrophy
Mendell, J. R., Moxley, R. T., Griggs, R. C., Brooke, M. H., Fenichel, G. M., Miller, J. P., King, W., Signore, L., Pandya, S., Florence, J., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906153202405 · Cited by 520
Self-citationBiggar, W. D., Harris, V. A., Eliasoph, L., & Alman, B. (2006) · Neuromuscular Disorders · doi:10.1016/j.nmd.2006.01.010 · Cited by 371
Duchenne muscular dystrophy: Patterns of clinical progression and effects of supportive therapy
Brooke, M. H., Fenichel, G. M., Griggs, R. C., Mendell, J. R., Moxley, R., Florence, J., King, W. M., Pandya, S., Robison, J., Schierbecker, J., et al. (1989) · Neurology · doi:10.1212/wnl.39.4.475 · Cited by 353
Self-citationEagle, M., Bourke, J., Bullock, R., Gibson, M., Mehta, J., Giddings, D., Straub, V., & Bushby, K. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2007.03.002 · Cited by 341
Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy
King, W. M., Ruttencutter, R., Nagaraja, H. N., Matkovic, V., Landoll, J., Hoyle, C., Mendell, J. R., & Kissel, J. T. (2007) · Neurology · doi:10.1212/01.wnl.0000260974.41514.83 · Cited by 283
Griggs, R. C. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530160047012 · Cited by 279
Long‐term benefit from prednisone therapy in Duchenne muscular dystrophy
Fenichel, G. M., Florence, J. M., Pestronk, A., Mendell, J. R., Moxley, R. T., Griggs, R. C., Brooke, M. H., Miller, J. P., Robison, J., King, W., et al. (1991) · Neurology · doi:10.1212/wnl.41.12.1874 · Cited by 263
Self-citationCiafaloni, E., Fox, D. J., Pandya, S., Westfield, C. P., Puzhankara, S., Romitti, P. A., Mathews, K. D., Miller, T. M., Matthews, D. J., Miller, L. A., et al. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.02.007 · Cited by 245
Self-citationPREDNISONE IN DUCHENNE MUSCULAR DYSTROPHY
Drachman, D. B., Toyka, K. V., & Myer, E. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90071-3 · Cited by 212
Corticosteroid Treatment and Functional Improvement in Duchenne Muscular Dystrophy: Long-Term Effect
Balaban, B., Matthews, D. J., Clayton, G. H., & Carry, T. (2005) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/01.phm.0000184156.98671.d0 · Cited by 184
Deflazacort Use in Duchenne Muscular Dystrophy: An 8-Year Follow-Up
Houde, S., Filiatrault, M., Fournier, A., Dubé, J., D’Arcy, S., Bérubé, D., Brousseau, Y., Lapierre, G., & Vanasse, M. (2008) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.11.001 · Cited by 182
Current treatment of adult Duchenne muscular dystrophy
Wagner, K. R., Lechtzin, N., & Judge, D. P. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.06.009 · Cited by 171
Clinical Investigation of Duchenne Muscular Dystrophy: Interesting Results in a Trial of Prednisone
Brooke, M. H., Fenichel, G. M., Griggs, R. C., Mendell, J. R., Moxley, R. T., Miller, J. P., Kaiser, K. K., Florence, J. M., Pandya, S., & Signore, L. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520200016010 · Cited by 157
Self-citationPrednisone Treatment in Duchenne Muscular Dystrophy: Long-term Benefit
DeSilva, S., Drachman, D. B., Mellits, D., & Kuncl, R. W. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520200022012 · Cited by 150
Rahbek, J., Werge, B., Madsen, A., Marquardt, J., Steffensen, B. F., & Jeppesen, J. (2005) · Developmental Neurorehabilitation · doi:10.1080/13638490400010191 · Cited by 142
Fenichel, G. M., Mendell, J. R., Moxley, R. T., Griggs, R. C., Brooke, M. H., Miller, J. P., Pestronk, A., Robison, J., King, W., Signore, L., et al. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530180027012 · Cited by 123
Self-citationPalliative care services in families of males with duchenne muscular dystrophy
Arias, R., Andrews, J., Pandya, S., Pettit, K. M., Trout, C. J., Apkon, S. D., Karwoski, J. B., Cunniff, C. M., Matthews, D. J., Miller, T. M., et al. (2011) · Muscle & Nerve · doi:10.1002/mus.22005 · Cited by 46
Self-citationSiegel, I. M., Je, M., & Rd, R. (1974) · PubMed · Cited by 32
Cited by
Duan, D., Goemans, N., Takeda, S., Mercuri, E., & Aartsma-Rus, A. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00248-3 · Cited by 1,312
Evidence-based path to newborn screening for Duchenne muscular dystrophy
Mendell, J. R., Shilling, C., Leslie, N. D., Flanigan, K. M., al‐Dahhak, R., Gastier‐Foster, J., Kneile, K., Dunn, D. M., Duval, B., Aoyagi, A., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23528 · Cited by 813
Duchenne and Becker Muscular Dystrophies
Flanigan, K. M. (2014) · Neurologic Clinics · doi:10.1016/j.ncl.2014.05.002 · Cited by 317
Duchenne Muscular Dystrophy: From Diagnosis to Therapy
Falzarano, M., Scotton, C., Passarelli, C., & Ferlini, A. (2015) · Molecules · doi:10.3390/molecules201018168 · Cited by 292
Involvement of adiponectin in the pathogenesis of dystrophinopathy
Abou-Samra, M., Lecompte, S., Schakman, O., Noel, L., Many, M. C., Gailly, P., & Brichard, S. M. (2015) · Skeletal Muscle · doi:10.1186/s13395-015-0051-9 · Cited by 55
Metadata
- Authors
- Moxley, R. T., Pandya, S., Ciafaloni, E., Fox, D. J., & Campbell, K.
- Venue
- Journal of Child Neurology
- Publisher
- SAGE Publications
- Published
- 2010-06-25
- Volume
- 25
- Issue
- 9
- Pages
- 1116-1129
- ISSN
- 0883-0738 (ISSN-L)
- 1708-8283
- OpenAlex
- W2047804604
- Cited by
- 280
- References
- 23
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.